Two cases of myelin oligodendrocyte glycoprotein antibody-associated disease presenting with Cauda Equina Syndrome without conus myelitis.

[1]  S. Broadley,et al.  Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[2]  T. Misu,et al.  Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy , 2020, Neurological Sciences.

[3]  M. Tintoré,et al.  Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease , 2020, Annals of Neurology.

[4]  K. Miyazawa,et al.  Refractory case of myelin oligodendrocyte glycoprotein antibody‐associated encephalomyelitis with lumbosacral radiculitis , 2020 .

[5]  Sruthi S. Nair,et al.  Relapsing lumbosacral myeloradiculitis: An unusual presentation of MOG antibody disease , 2020, Multiple sclerosis.

[6]  A. Carson,et al.  The clinical features and outcome of scan-negative and scan-positive cases in suspected cauda equina syndrome: a retrospective study of 276 patients , 2018, Journal of Neurology.

[7]  D. Rubin,et al.  MOG antibodies in combined central and peripheral demyelination syndromes , 2018, Neurology: Neuroimmunology & Neuroinflammation.

[8]  Jacqueline Palace,et al.  MOG encephalomyelitis: international recommendations on diagnosis and antibody testing , 2018, Journal of Neuroinflammation.

[9]  Y. Itoyama,et al.  Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody , 2012, Neurology.

[10]  Y. Rajabally,et al.  Neuropathy and paraproteins: review of a complex association , 2011, European journal of neurology.

[11]  J. Vallat,et al.  CNS/PNS Boundary Transgression by Central Glia in the Absence of Schwann Cells or Krox20/Egr2 Function , 2010, The Journal of Neuroscience.

[12]  D. Zochodne.  Diabetic polyneuropathy: an update , 2008, Current opinion in neurology.